1. Home
  2. AMBO vs INDP Comparison

AMBO vs INDP Comparison

Compare AMBO & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBO
  • INDP
  • Stock Information
  • Founded
  • AMBO 2000
  • INDP 2000
  • Country
  • AMBO United States
  • INDP United States
  • Employees
  • AMBO N/A
  • INDP N/A
  • Industry
  • AMBO Other Consumer Services
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBO Real Estate
  • INDP Health Care
  • Exchange
  • AMBO Nasdaq
  • INDP Nasdaq
  • Market Cap
  • AMBO 8.8M
  • INDP 7.4M
  • IPO Year
  • AMBO 2010
  • INDP N/A
  • Fundamental
  • Price
  • AMBO $3.19
  • INDP $0.42
  • Analyst Decision
  • AMBO
  • INDP Strong Buy
  • Analyst Count
  • AMBO 0
  • INDP 2
  • Target Price
  • AMBO N/A
  • INDP $8.50
  • AVG Volume (30 Days)
  • AMBO 27.3K
  • INDP 42.8K
  • Earning Date
  • AMBO 12-30-2024
  • INDP 05-14-2025
  • Dividend Yield
  • AMBO N/A
  • INDP N/A
  • EPS Growth
  • AMBO N/A
  • INDP N/A
  • EPS
  • AMBO 0.11
  • INDP N/A
  • Revenue
  • AMBO $9,392,000.00
  • INDP N/A
  • Revenue This Year
  • AMBO N/A
  • INDP N/A
  • Revenue Next Year
  • AMBO N/A
  • INDP N/A
  • P/E Ratio
  • AMBO $28.89
  • INDP N/A
  • Revenue Growth
  • AMBO 2.50
  • INDP N/A
  • 52 Week Low
  • AMBO $1.00
  • INDP $0.43
  • 52 Week High
  • AMBO $5.55
  • INDP $3.10
  • Technical
  • Relative Strength Index (RSI)
  • AMBO 59.88
  • INDP 36.36
  • Support Level
  • AMBO $3.02
  • INDP $0.40
  • Resistance Level
  • AMBO $3.39
  • INDP $0.48
  • Average True Range (ATR)
  • AMBO 0.32
  • INDP 0.05
  • MACD
  • AMBO 0.01
  • INDP 0.01
  • Stochastic Oscillator
  • AMBO 64.37
  • INDP 38.75

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: